Tirzepatide
A 39-residue, fatty-acylated peptide analogue with activity at GIP and GLP-1 receptors.
Products are offered exclusively for lawful laboratory research by qualified personnel. Not for human or veterinary use. Not intended for diagnosis, treatment, cure, prevention, mitigation, clinical use, food, drug, cosmetic, household, or consumer use.
Product Description
Tirzepatide is a synthetic 39-residue peptide based on the glucose-dependent insulinotropic polypeptide (GIP) sequence. Its structure includes α-aminoisobutyric acid substitutions, a C-terminal amide, and a C20 fatty diacid attached through a linker at Lys20. It is studied in GIP-receptor and GLP-1-receptor signaling systems.
Property Information
Reference chemistry for the stated structure; added counterions, hydration, and lot-specific analytical results are documented separately.
| Property | Information |
|---|---|
| Chemical identity | Tirzepatide |
| CAS number | 2023788-19-2 |
| Chain length | 39 amino acids |
| Sequence / structure | Modified linear peptide; Aib2/Aib13; C-terminal amide; Lys20-linked C20 fatty diacid |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.5 g/mol |
| Purity | Lot-specific analytical results available upon request |
| Documentation | Available upon request |
Research References
Quality Assurance & Analytical Documentation
MP Research maintains analytical documentation for its research materials, including available third-party testing and lot-specific quality records.
Certificates of Analysis are maintained as part of our quality assurance program and are available upon request for the applicable product and lot.
For documentation requests, please contact MP Research with the product name and lot number.
All materials are intended strictly for legitimate laboratory research and are not intended for human or veterinary use.




